A review of nonsteroidal anti-inflammatory drugs

AANA Journal

Volumn 83, Issue 6, 2015, Pages 425-433

  Bozimowski, Gregory ^a  

^a UNIVERSITY OF DETROIT MERCY   (United States)

Author keywords

Adverse drug effects; Drug interactions; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ICOSANOID; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROPIONIC ACID DERIVATIVE; PROSTAGLANDIN SYNTHASE;

ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; FRACTURE HEALING; GASTROINTESTINAL HEMORRHAGE; HUMAN; INHIBITION KINETICS; LIVER TOXICITY; NEPHROTOXICITY; NURSE ANESTHETIST; PHARMACOLOGY; POSTOPERATIVE HEMORRHAGE; SIGNAL TRANSDUCTION; THROMBOCYTE; UNSPECIFIED SIDE EFFECT; CONTINUING EDUCATION; EDUCATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EDUCATION, CONTINUING; HUMANS; NURSE ANESTHETISTS;

EID: 84951968508     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Vandraas KF, Spigset O, Mahic M, Slørdal L. Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly. Eur J Clin Pharmacol. 2010;66(8):823-829.
2. Atkinson TJ, Fudin J, Jahn HL, Kubotera N, Rennick AL, Rhorer M. What's new in NSAID pharmacotherapy: oral agents to injectables. Pain Med. 2013;14(suppl 1):S11-S17.
3. Haeggström JZ, Rinaldo-Matthis A, Wheelock CE, Wetterholm A. Advances in eicosanoid research, novel therapeutic implications. Biochem Biophys Res Commun. 2010;396(1):135-139.
4. Feucht CL, Patel DR. Analgesics and anti-inflammatory medications in sports: use and abuse. Pediatr Clin North Am. 2010;57(3):751-774.
5. Gajraj NM. Cyclooxygenase-2 inhibitors. Anesth Analg. 2003;96(6): 1720-1738.
6. Vonkeman HE, van de Laar MA. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum. 2010;39(4):294-312.
7. Amer M, Bead VR, Bathon J, Blumenthal RS, Edwards DN. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale. Cardiol Rev. 2010;18(4):204-212.
8. Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009;8(6):669-681.
9. Micromedex Healthcare Series. Version 5.1. Greenwood Village, CO: Truven Health Analytics.
10. Thomas S, Katbab H, abu Fanas SH. Do preoperative cutaneous bleeding time tests predict the outcome of intraoral surgical bleeding? Int Dent J. 2010;60(4):305-310.
11. Hakkarainen TW, Steele SR, Bastaworous A, et al. Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure: a report from Washington State's Surgical Care and Outcomes Assessment Program (SCOAP) [published online January 21, 2015; published correction appears in JAMA Surg. 2015;150(5):492]. JAMA Surg. 2015;150(3):223-228.
12. Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364(9450):2021-2029.
13. Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol. 2003;111(5, suppl 1):1116-1121.
14. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111(5, suppl 1):913-921.
15. Baptist AP, Reddy RC. Inhaled corticosteroids for asthma: are they all the same? J Clin Pharm Ther. 2009;34(1):1-12.
16. Forwood MR. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res. 1996;11(11):1688-1693.
17. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res. 2002;17(6):963-976.
18. Cottrell J, O'Connor JP. Effect of non-steroidal anti-inflammatory drugs on bone healing. Pharmaceuticals. 2010;3(5):1668-1693.
19. Cuzick J, Thorat MA, Bosetti C, et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2014;26(1):47-57.
20. Chan AT, Ogino S, Giovannucci EL, Fuchs CS. Inflammatory markers are associated with risk of colorectal cancer and chemopreventative response to anti-inflammatory drugs. Gastroenterology. 2011;140(3):799-808.
21. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377(9759):31-41.
22. Mackenzie IS, Coughtrie MW, MacDonald TM, Wei L. Antiplatelet drug interactions. J Intern Med. 2010;268(6):516-529.
23. Zelcer S, Kolesnikov Y, Kovalyshyn I, Pasternak DA, Pasternak GW. Selective potentiation of opioid analgesia by nonsteroidal anti-inflammatory drugs. Brain Res. 2005;1040(1-2):151-156.
24. Kolesnikov YA, Wilson RS, Pasternak GW. The synergistic analgesic interactions between hydrocodone and ibuprofen. Anesth Analg. 2003;97(6):1721-1723.
25. Nanau RM, Neuman MG. Ibuprofen-induced hypersensitivity syndrome. Transl Res. 2010;155(6):275-293.
26. Ketorolac tromethamine (Toradol) [package insert]. Basel, Switzerland: Roche. http://www.accessdata.fda.gov/drugsatfda_docs/ label/2013/019645s019lbl.pdf. Accessed January 1, 2015.
27. Caldolor (ibuprofen) injection [prescribing information]. Nashville, TN: Cumberland Pharmaceuticals Inc. http://www.caldolor.com/ wp-content/uploads/caldolor_prescribing_information.pdf. Accessed September 24, 2015.
28. Ofirmev (acetaminophen) injection [prescribing information]. http:// www.accessdata.fda.gov/drugsatfda_docs/label/2010/022450lbl.pdf. Accessed March 6, 2015.
29. Bookstaver PB, Miller AD, Rudisill CN, Norris LB. Intraveous ibuprophen: the first injectable product for the treatment of pain and fever. J Pain Res. 2010;3:67-79.
30. Southworth S, Peters J, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009;31(9):1922-1935.
31. Conklin DR, Eisenach JC. Intrathecal ketorolac enhances antinociception from clonidine. Anesth Analg. 2003;96(1):191-194.
32. Mattia A, Coluzzi F. What anesthesiologists should know about paracetamol (acetaminophen). Minerva Anestesiol. 2009;75(11):644-653.
33. Zhang Q, Bal-dit-Sollier C, Druet L, et al. Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial. Eur J Clin Pharmacol. 2011;67(3):309-314.
34. Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: an updated review. Arch Toxicol. 2015;89(2):193-199.
35. Guggenheimer J, Moore PA. The therapeutic applications of and risks associated with acetaminophen use: a review and update. J Am Dent Assoc. 2011;142(1):38-44.
36. Kostrubsky SE, Sinclair JF, Strom SC, et al. Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes. Toxicol Sci. 2005;87(1):146-155.
37. Ghosh J, Das J, Manna P, Sil PC. Acetaminophen induced renal injury via oxidative stress and TNF-alpha production: therapeutic potential of arjunolic acid. Toxicology. 2010;268(1-2):8-18.
38. Evans M, Fored CM, Bellocco R, et al. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant. 2009;24(6):1908-1918.
39. Wininger SJ, Miller H, Minkowitz HS, et al. A randomized, doubleblind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clin Ther. 2010;32(14):2348-2369.
40. Maund E, McDaid C, Rice S, Wright K, Jenkins B, Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related sideeffects after major surgery: a systematic review. Br J Anaesth. 2011;106(3):292-297.
41. Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102(4):822-831.
42. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther. 2007;29(11, suppl 1):2477-2497.
43. Choi KH, Kim AJ, Son IJ, et al. Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting. J Korean Med Sci. 2010;25(3):337-341.
44. Snowden S, Nelson R. The effects of nonsteroidal anti-inflammatory drugs on blood pressure in hypertensive patients. Cardiol Rev. 2011;19(4):184-191.
45. Seed SM, Dunican KC, Lynch AM. Osteoarthritis: a review of treatment options. Geriatrics. 2009;64(10):20-28.
46. Ishiguro C, Fujita T, Omori T, Fujii Y, Mayama T, Sato T. Assessing the effects of non-steroidal anti-inflammatory drugs on antihypertensive drug therapy using post-marketing surveillance database. J Epidemiol. 2008;18(3):119-124.
47. Sudano I, Flammer AJ, Périat D, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010;122(18):1789-1796.
48. Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565-1575.
49. de Jong JCF, van den Berg PB, Tobi H, de Jong-van den Berg LT. Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects. Br J Clin Pharmacol. 2003;55(6):591-595.
50. Vidal X, Ibáñez L, Vendrell L, Conforti A, Laporte JR; Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study. Drug Saf. 2008;31(2):159-168.